56% overturnedAppeal outcomes · Imaging

Denied endoscopy: what independent reviewers actually decided

Endoscopy denials are interval and indication disputes, and the winning records establish duration before they establish anything else.

Diagnostic upper or lower endoscopy billed with procedure-specific codes, denied for interval, indication or as duplicative of a recent study.

What the independent reviewers decided

56%

overturned by the independent reviewer

23

of 41 decisions in the corpus

Source

California DMHC independent medical review determinations, 2017-2026. Public record.

Read this as a base rate, not as your odds

These are decisions about other patients, in one state, that had already been through the plan's own internal appeal and were then sent to an outside reviewer. That population is self-selected toward disputes worth pursuing, so the rate says what happened to cases like this at that stage — not what will happen to a specific claim. It is not medical or legal advice.

Why plans deny endoscopy

  • A repeat study falls inside a surveillance interval the policy restricts.
  • The indication is characterised as not requiring endoscopic evaluation at this stage.
  • A trial of medical therapy the policy requires is not documented.
  • The study is read as screening outside the policy's age or risk window.

What actually carried the cases that won

Chronicity led the reversals — persistence of symptoms through a documented course of treatment. This is a smaller sample than the other imaging-group procedures, so the rate should be read with that in mind, but the direction is consistent: establish the duration and the failed medical therapy, then the indication. Clinical guidelines and specialty-society criteria were the authorities.

What the record showedShare of overturned decisions
The condition was documented as chronic or long-standing57%
A published guideline supported the request48%
Conservative treatment was documented as failed30%
Objective findings were documented30%
The diagnosis was confirmed26%
Prior treatment was documented17%
The functional impact on the patient was documented13%
The severity or urgency was documented9%

Shares are of the overturned decisions and do not sum to 100% — a single decision often rested on more than one, and some rested on none of these.

What the reviewers cited

  • Clinical guidelines — in 61% of the overturned decisions
  • Specialty-society criteria — in 48% of the overturned decisions
  • Peer-reviewed literature — in 39% of the overturned decisions
  • Standard of care — in 4% of the overturned decisions

endoscopy denials — frequently asked

Is a denied endoscopy worth appealing?
Twenty-three of the 41 endoscopy disputes California reviewers decided were reversed. Forty-one decisions is a modest base, so treat that as a direction rather than a precise figure.
How are surveillance-interval denials answered?
With a documented change — new symptoms, a new finding, a failed treatment — rather than an argument that the interval should not apply.
Does a failed medical trial matter for a diagnostic study?
Where the policy requires one, yes. Persistence through treatment is what the chronicity finding in these decisions reflects, and it is what turns a symptom into an indication in the policy's terms.

Related guides

CO-50 — not medically necessaryGastroenterology denialsDuplicate claim denials

Source

Denial reasons and criteria are described in plain language for reference and vary by plan and policy. This page reports what independent reviewers decided in a public California dataset; it is general information, not medical, legal, or coverage advice.

When the appeal has to be written, and cited

Upload the denied EOB and Merits returns a complete, citation-verified appeal letter — the clinical argument, the payer's own coverage criteria, and your federal appeal rights — in about a minute.

Appeal a denial →